No. 98 | GLP-1 normalized injectable health optimization for 25 million Americans. The gray market proved peptide demand at scale. The infrastructure is forming and the category is igniting.
Ozempic Was the Amuse-Bouche
No. 98 | GLP-1 normalized injectable health optimization for 25 million Americans. The gray market proved peptide demand at scale. The infrastructure is forming and the category is igniting.